🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Safety: To describe the safety profiles following vaccination. Immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00621764
The purpose of this study is to determine non-inferiority in seroconversion...
Status
Completed
Location
Clinical Pharamacology Center
Start Date
2005-05
Trial ID
NCT00319592
Treatments Being Tested
The purpose of this study is to obtain safety, tolerability, and immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00982137
This randomised, double-blind study is to be conducted on 96 subjects at mu...
Status
Completed
Location
Dr Atul's Child Hospital
Start Date
2007-01
Trial ID
NCT00441259
Treatments Being Tested
The purpose of this study is to determine non-inferiority in seroconversion...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00314145
Treatments Being Tested
The purpose of this study is to assess whether ChimeriVax™ JE vaccine (a ne...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00314132
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00981175
This study is to assess the safety and immunogenicity of three consecutive ...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00735644
The purpose of this study is to assess the safety, tolerability, and immuno...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00981630